Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
ESCITALOPRAM GH (Lupin Australia Pty Limited)
Product name
ESCITALOPRAM GH
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
18 working days (45)
Active ingredients
escitalopram oxalate
Registration type
EOI
Indication
Generic medicine
ESCITALOPRAM GH (film coated tablets) is now also indicated for:
- Treatment of social anxiety disorder (social phobia).
- Treatment of generalised anxiety disorder.